Thomas E. Starzl Transplantation Institute, Department of Surgery.
Pittsburgh Liver Research Center.
J Clin Invest. 2021 Nov 1;131(21). doi: 10.1172/JCI154096.
Direct allorecognition, the ability of host T cells to recognize intact allogeneic MHC molecules on transplanted tissues, is often assumed to be less dependent on the peptide bound to the MHC molecule than are other antigen recognition pathways. In this issue of the JCI, Son et al. provide unequivocal, in vivo evidence that direct allorecognition depends on the self-peptides bound to the non-self MHC molecule. The authors demonstrate that the induction of allospecific tolerance required the presentation of self-peptides by the non-self MHC molecule, and that only a handful of these peptides accounted for a sizeable proportion of the immunogenicity of the MHC antigen. These are important findings for transplant immunologists because they provide molecular insights into the biology of direct allorecognition, the prime driver of the alloimmune response to MHC-mismatched grafts, and much-needed tools, peptide-MHC multimers, to track and study polyclonal alloreactive T cells.
直接同种异体识别,即宿主 T 细胞识别移植组织上完整同种异体 MHC 分子的能力,通常被认为比其他抗原识别途径较少依赖于与 MHC 分子结合的肽。在本期 JCI 中,Son 等人提供了明确的体内证据,表明直接同种异体识别取决于与非自身 MHC 分子结合的自身肽。作者证明,诱导同种特异性耐受需要非自身 MHC 分子呈递自身肽,并且只有少数这些肽占 MHC 抗原免疫原性的相当大比例。这些发现对于移植免疫学家来说非常重要,因为它们为直接同种异体识别的生物学提供了分子见解,直接同种异体识别是 MHC 错配移植物同种免疫反应的主要驱动因素,也是急需的工具,即肽-MHC 多聚体,用于跟踪和研究多克隆同种反应性 T 细胞。